ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGrath, L. B.
Right arrow Articles by Restrepo, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGrath, L. B.
Right arrow Articles by Restrepo, D.

The Annals of Thoracic Surgery, Vol 43, 285-287, Copyright © 1987 by The Society of Thoracic Surgeons

ARTICLES

Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents

LB McGrath, L Gonzalez-Lavin, WJ Eldredge, M Colombi and D Restrepo

To determine if anticoagulation therapy is necessary after valve replacement with the St. Jude Medical prosthesis in young subjects, 30 consecutive patients were studied. They ranged in age from 4 to 20 years, and each had undergone valve replacement some time between February, 1982, and June, 1984. There was 1 hospital death (3.3%; 70% confidence limits [CL] = 0.4% to 10.9%). The 29 hospital survivors were treated with aspirin and dipyridamole. All patients were followed up. There were 5 late deaths (17.2%; 70% CL = 9% to 27%), at a mean of 8 months postoperatively. Follow-up revealed that 7 thromboembolic events occurred in 7 of the hospital survivors (24.1%; 70% CL = 15% to 35%). Hemiparesis occurred in 1 patient, and documented valve thrombosis and death occurred in another. Transient sensorimotor deficits were found in the 5 other patients. Prosthetic valve endocarditis developed in 1 hospital survivor (3.5%; 70% CL = 0.4% to 11%) and resulted in late death. There were no reoperations in the hospital survivors. We conclude that the St. Jude Medical prosthesis is useful for valve replacement in the young because of its low profile, durability, and hemodynamic characteristics. However, we recommend that these patients receive full anticoagulation therapy.


This article has been cited by other articles:


Home page
 ChestHome page
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker
Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 593S - 629S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson
Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 887S - 968S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker
Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 457S - 482S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson
Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 645S - 687S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew
Antithrombotic Therapy in Children
Chest, January 1, 2001; 119(1_suppl): 344S - 370S.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud
Anticoagulation in Children With Mechanical Valve Prostheses
Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34.
[Abstract] [Full Text]

Home page
 CirculationHome page
F. M. Lupinetti, J. Warner, T. K. Jones, and S. P. Herndon
Comparison of Human Tissues and Mechanical Prostheses for Aortic Valve Replacement in Children
Circulation, July 1, 1997; 96(1): 321 - 325.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
K. Hisatomi, T. Isomura, T. Sato, K. Kosuga, K. Ohishi, and H. Katoh
Mitral Valve Repair for Mitral Regurgitation With Ventricular Septal Defect in Children
Ann. Thorac. Surg., December 1, 1996; 62(6): 1773 - 1777.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Pouleur and M. Buyse
EFFECTS OF DIPYRIDAMOLE IN COMBINATION WITH ANTICOAGULANT THERAPY ON SURVIVAL AND THROMBOEMBOLIC EVENTS IN PATIENTS WITH PROSTHETIC HEART VALVESA meta-analysis of the randomized trials
J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 463 - 472.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Ibrahim, J. Cleland, H. O'Kane, D. Gladstone, C. Mullholland, and B. Craig
St. Jude Medical prosthesis in children
J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 52 - 56.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Fernandez, G. W. Laub, M. S. Adkins, W. A. Anderson, C. Chen, B. M. Bailey, L. M. Nealon, and L. B. McGrath
Early and late-phase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 394 - 407.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.